1. Home
  2. SLRC vs AVDL Comparison

SLRC vs AVDL Comparison

Compare SLRC & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRC
  • AVDL
  • Stock Information
  • Founded
  • SLRC 2007
  • AVDL 2015
  • Country
  • SLRC United States
  • AVDL Ireland
  • Employees
  • SLRC N/A
  • AVDL N/A
  • Industry
  • SLRC Finance/Investors Services
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLRC Finance
  • AVDL Health Care
  • Exchange
  • SLRC Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • SLRC 885.4M
  • AVDL 993.5M
  • IPO Year
  • SLRC 2010
  • AVDL 1996
  • Fundamental
  • Price
  • SLRC $16.37
  • AVDL $10.61
  • Analyst Decision
  • SLRC Sell
  • AVDL Strong Buy
  • Analyst Count
  • SLRC 4
  • AVDL 6
  • Target Price
  • SLRC $15.25
  • AVDL $24.00
  • AVG Volume (30 Days)
  • SLRC 171.1K
  • AVDL 1.1M
  • Earning Date
  • SLRC 11-06-2024
  • AVDL 11-12-2024
  • Dividend Yield
  • SLRC 10.02%
  • AVDL N/A
  • EPS Growth
  • SLRC 34.99
  • AVDL N/A
  • EPS
  • SLRC 1.77
  • AVDL N/A
  • Revenue
  • SLRC $236,635,000.00
  • AVDL $138,160,000.00
  • Revenue This Year
  • SLRC $4.11
  • AVDL $523.86
  • Revenue Next Year
  • SLRC N/A
  • AVDL $70.46
  • P/E Ratio
  • SLRC $9.23
  • AVDL N/A
  • Revenue Growth
  • SLRC 5.79
  • AVDL 1523.50
  • 52 Week Low
  • SLRC $14.41
  • AVDL $9.41
  • 52 Week High
  • SLRC $16.91
  • AVDL $19.09
  • Technical
  • Relative Strength Index (RSI)
  • SLRC 52.94
  • AVDL 46.37
  • Support Level
  • SLRC $15.79
  • AVDL $9.97
  • Resistance Level
  • SLRC $16.21
  • AVDL $10.53
  • Average True Range (ATR)
  • SLRC 0.24
  • AVDL 0.47
  • MACD
  • SLRC -0.07
  • AVDL 0.12
  • Stochastic Oscillator
  • SLRC 51.79
  • AVDL 61.43

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Share on Social Networks: